Rehabilitation Research and Practice / 2011 / Article / Tab 2

Clinical Study

Treatment of Fatigue in Multiple Sclerosis Patients: A Neurocognitive Approach

Table 2

Mean clinical variables scores at baseline and 6 months after treatment ( 𝑛 = 1 8 ).

VariableBaseline
mean (SD)
Second follow-up
mean (SD)
𝑃

EDSS2.50 (1.34)2.53 (1.63)N.S.

FSS5.72 (0.47)4.17 (1.31)<0.0001

MFIS36.67 (13.76)26.78 (17.65)0.010
 pMFIS20.28 (6.35)15.71 (8.87)0.025
 cMFIS14.33 (8.20)9.72 (8.50)0.009
 psMFIS2.06 (2.01)1.33 (1.81)0.054

MSFC0.10 (0.63)0.22 (0.64)0.122
 NHPT22.21 (5.96)20.97 (4.44)0.220
 25FWT5.80 (1.83)5.77 (2.57)0.108
 PASAT39.56 (12.45)41.89 (14.41)0.216

MSQOL-54
 PHCS52.80 (16.64)60.78 (17.80)0.049
 MHCS61.19 (15.56)65.03 (18.48)0.309

EDDS: Expanded Disability Status Scale, MSFC: Multiple Sclerosis Functional Composite, NHPT: Nine-Hole Peg Test, 25 FWT: 25-Foot Walking Test, PASAT: Paced Auditory Serial Addition Test, FSS: Fatigue Severity Scale, MFIS: Modified Fatigue Impact Scale, pMFIS: physical MFIS subscale, cMFIS: cognitive MFIS subscale, psMFIS: psychosocial MFIS subscale, MSQOL-54: Multiple Sclerosis Quality of Life Questionnaire, PHCS: Physical Health Composite Score, MHCS: Mental Health Composite Score.